Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.

MLA

Kruczynski, Anna, et al. “Anti-Angiogenic, Vascular-Disrupting and Anti-Metastatic Activities of Vinflunine, the Latest Vinca Alkaloid in Clinical Development.” European Journal of Cancer (Oxford, England : 1990), vol. 42, no. 16, Nov. 2006, pp. 2821–32. EBSCOhost, https://doi.org/10.1016/j.ejca.2006.06.019.

APA

Kruczynski, A., Poli, M., Dossi, R., Chazottes, E., Berrichon, G., Ricome, C., Giavazzi, R., Hill, B. T., & Taraboletti, G. (2006). Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. European Journal of Cancer (Oxford, England : 1990), 42(16), 2821–2832. https://doi.org/10.1016/j.ejca.2006.06.019

Chicago

Kruczynski, Anna, Maura Poli, Romina Dossi, Eric Chazottes, Géraldine Berrichon, Christel Ricome, Raffaella Giavazzi, Bridget T Hill, and Giulia Taraboletti. 2006. “Anti-Angiogenic, Vascular-Disrupting and Anti-Metastatic Activities of Vinflunine, the Latest Vinca Alkaloid in Clinical Development.” European Journal of Cancer (Oxford, England : 1990) 42 (16): 2821–32. doi:10.1016/j.ejca.2006.06.019.